Role of Tumor Necrosis Factor-a Promoter Polymorphism and Insulin Resistance in the Development of Non-alcoholic Fatty Liver Disease in Obese Children

다국어 초록 (Multilingual Abstract)

Purpose: Tumor necrosis factor-α (TNF-α) polymorphism has been suggested to play an important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) in obese adults, and known to be a mediator of insulin resistance. In this study, we evaluated the role of TNF-α promoter polymorphisms and insulin resistance in the development of NAFLD in obese children. Methods: A total of 111 obese children (M：F=74：37; mean age, 11.1±2.0 yrs) were included. The children were divided into 3 groups: controls (group I, n=61), children with simple steatosis (group II, n=17), and children with non-alcoholic steatohepatitis (group III, n=33). Serum TNF-α levels, homeostasis model assessment of insulin resistance (HOMA-IR), and TNF-α -308 and -238 polymorphisms were evaluated. Results: There were no differences in TNF-α polymorphism at the -308 or the -238 loci between group I and group II + III (p=0.134 and p=0.133). The medians of HOMA-IR were significantly different between group I and group II + III (p=0.001), with significant difference between group II and group III (p=0.007). No difference was observed in the HOMA-IR among the genotypes at the -308 locus (p=0.061) or the -238 locus (p=0.207) in obese children. Conclusion: TNF-α promoter polymorphisms at the -308 and -238 loci were not significantly associated with the development of NAFLD in children; nevertheless, insulin resistance remains a likely essential factor in the pathogenesis of NAFLD in obese children, especially in the progression to NASH.

참고문헌 (Reference)

1 Kim TH, "Tumor necrosis factor-α and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease" 42 : 377-386, 2003

2 Hu ZW, "Tumor necrosis factor-alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases" 72 : 215-221, 2009

3 Valenti L, "Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease" 122 : 274-280, 2002

4 Powell EE, "The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years" 11 : 74-80, 1990

5 Day CP, "Steatohepatitis: a tale of two “hits”?" 114 : 842-845, 1998

6 Chu CJ, "Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha" 54 : 2099-2102, 2007

7 Uysal KT, "Protection from obesity-induced insulin resistance in mice lacking TNF-α function" 389 : 610-614, 1997

8 Molleston JP, "Obese children with steatohepatitis can develop cirrhosis in childhood" 97 : 2460-2462, 2002

9 Brunt EM, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions" 94 : 2467-2474, 1999

10 Ludwig J, "Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease" 55 : 434-438, 1980

11 Polyzos SA, "Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines" 9 : 299-314, 2009

12 Matteoni CA, "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity" 116 : 1413-1419, 1999

13 Tilg H, "Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance" 131 : 934-945, 2006

14 Lavine JE, "Nonalcoholic fatty liver disease in the pediatric population" 8 : 549-558, 2004

15 Bugianesi E, "Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?" 36 : 165-173, 2004

16 Strauss S, "Interobserver and intraobserver variability in the sonographic assessment of fatty liver" 189 : 320-323, 2007

17 Aller R, "Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease" 53 : 1088-1092, 2008

18 Hajeer AH, "Influence of TNFα gene polymorphisms on TNFα production and disease" 62 : 1191-1199, 2001

19 Tokushige K, "Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis" 46 : 1104-1110, 2007

20 Hotamisligil GS, "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance" 95 : 2409-2415, 1995

21 Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man" 28 : 412-419, 1985

22 Wong VW, "Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people" 23 : 914-921, 2008

23 Crespo J, "Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients" 34 : 1158-1163, 2001

24 Aller R, "G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients" 9 : 439-444, 2010

25 Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease" 41 : 1313-1321, 2005

26 Manco M, "Correlation of serum TNF-α levels and injury scores in pediatric nonalcoholic fatty" 127 : 954-960, 2007

27 Hui JM, "Beyond insulin resistance in NASH: TNF-alpha or adiponectin?" 40 : 46-54, 2004

28 Marchesini G, "Association of nonalcoholic fatty liver disease with insulin resistance" 107 : 450-455, 1999

29 Grove J, "Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis" 26 : 143-146, 1997

30 문진수, "2007 한국 소아 청소년 성장도표 : 개발 과정과 전망" 대한소아과학회 51 (51): 1-25, 2008